Efficacy and safety of darunavir/ritonavir at 48 weeks in treatment-naïve, HIV-1-infected adolescents: Results from a Phase 2 open-label trial (DIONE)

Patricia Flynn; Svitlana Komar; Stephane Blanche; Carlo Giaquinto; Antoni Noguera-Julian; Steven Welch; Erkki Lathouwers; Tom Van De Casteele; Thomas N. Kakuda; Magda Opsomer

doi:10.1097/INF.0000000000000308

Efficacy and safety of darunavir/ritonavir at 48 weeks in treatment-naïve, HIV-1-infected adolescents: Results from a Phase 2 open-label trial (DIONE)

Patricia Flynn, Svitlana Komar, Stephane Blanche, Carlo Giaquinto, Antoni Noguera-Julian, Steven Welch, Erkki Lathouwers, Tom Van De Casteele, Thomas N. Kakuda, Magda Opsomer

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	940-945
Number of pages	6
Journal	Pediatric Infectious Disease Journal
Volume	33
Issue number	9
DOIs	https://doi.org/10.1097/INF.0000000000000308
State	Published - 2014

ASJC Scopus Subject Areas

Pediatrics, Perinatology, and Child Health
Microbiology (medical)
Infectious Diseases

Keywords

Adolescents
Darunavir
HIV-1
Ritonavir
Treatment-naïve

Access to Document

10.1097/INF.0000000000000308

OpenUrl availability

Full text

Cite this

Flynn, P., Komar, S., Blanche, S., Giaquinto, C., Noguera-Julian, A., Welch, S., Lathouwers, E., Van De Casteele, T., Kakuda, T. N., & Opsomer, M. (2014). Efficacy and safety of darunavir/ritonavir at 48 weeks in treatment-naïve, HIV-1-infected adolescents: Results from a Phase 2 open-label trial (DIONE). Pediatric Infectious Disease Journal, 33(9), 940-945. https://doi.org/10.1097/INF.0000000000000308

Flynn, P, Komar, S, Blanche, S, Giaquinto, C, Noguera-Julian, A, Welch, S, Lathouwers, E, Van De Casteele, T, Kakuda, TN & Opsomer, M 2014, 'Efficacy and safety of darunavir/ritonavir at 48 weeks in treatment-naïve, HIV-1-infected adolescents: Results from a Phase 2 open-label trial (DIONE)', Pediatric Infectious Disease Journal, vol. 33, no. 9, pp. 940-945. https://doi.org/10.1097/INF.0000000000000308

@article{9086991fc99b4f6597985b5a42281489,

title = "Efficacy and safety of darunavir/ritonavir at 48 weeks in treatment-na{\"i}ve, HIV-1-infected adolescents: Results from a Phase 2 open-label trial (DIONE)",

keywords = "Adolescents, Darunavir, HIV-1, Ritonavir, Treatment-na{\"i}ve",

author = "Patricia Flynn and Svitlana Komar and Stephane Blanche and Carlo Giaquinto and Antoni Noguera-Julian and Steven Welch and Erkki Lathouwers and {Van De Casteele}, Tom and Kakuda, {Thomas N.} and Magda Opsomer",

note = "Publisher Copyright: Copyright {\textcopyright} 2014 by Lippincott Williams & Wilkins.",

year = "2014",

doi = "10.1097/INF.0000000000000308",

language = "English",

volume = "33",

pages = "940--945",

journal = "Pediatric Infectious Disease Journal",

issn = "0891-3668",

number = "9",

}

TY - JOUR

T1 - Efficacy and safety of darunavir/ritonavir at 48 weeks in treatment-naïve, HIV-1-infected adolescents

T2 - Results from a Phase 2 open-label trial (DIONE)

AU - Flynn, Patricia

AU - Komar, Svitlana

AU - Blanche, Stephane

AU - Giaquinto, Carlo

AU - Noguera-Julian, Antoni

AU - Welch, Steven

AU - Lathouwers, Erkki

AU - Van De Casteele, Tom

AU - Kakuda, Thomas N.

AU - Opsomer, Magda

PY - 2014

Y1 - 2014

KW - Adolescents

KW - Darunavir

KW - HIV-1

KW - Ritonavir

KW - Treatment-naïve

UR - http://www.scopus.com/inward/record.url?scp=84913585259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84913585259&partnerID=8YFLogxK

U2 - 10.1097/INF.0000000000000308

DO - 10.1097/INF.0000000000000308

M3 - Article

C2 - 25361024

AN - SCOPUS:84913585259

SN - 0891-3668

VL - 33

SP - 940

EP - 945

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

IS - 9

ER -

Efficacy and safety of darunavir/ritonavir at 48 weeks in treatment-naïve, HIV-1-infected adolescents: Results from a Phase 2 open-label trial (DIONE)

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this